Cancer Epidemiology, screening, Diagnosis & Prognosis

The Epidemiology of Cancer is the study of the factors affecting Cancer, a way to conclude possible tendencies and causes. The study of Cancer Epidemiology practices Epidemiological Methods to discover the cause of Cancer and to recognize and develop enhanced treatments. This extent of study must cope with difficulties of lead time bias and length time bias. Lead time bias is the theory that primary diagnosis may artificially inflate the survival statistics of a Cancer, without actually improving the natural history of the disease. Length bias is the concept that tender growing, more lethargic Tumors are more likely to be recognised by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs.

Most Cancers are originally known either because of the appearance of signs or symptoms or through Screening. Neither of these leads to a Definitive Diagnosis, which comprises the examination of a tissue sample by a pathologist. People with suspected Cancer are observed with medical tests. These generally include Blood Tests, CT Scans, X-rays and Endoscopy.

Screenings can find initial Cancer, when it’s most curable. Cancer Screening aims to identify Cancer before symptoms appear. This may include blood tests, urine tests, other tests, or Medical Imaging. The aids of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed beside any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a definite age group. Selective Screening detects people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Circulating tumor cells (CTCs) towards cancer Diagnosis
  • Microfluidic device for cancer screening
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Early detection and diagnosis of Cancer

Related Conference of Cancer Epidemiology, screening, Diagnosis & Prognosis

February 25-26, 2021

5th Global summit on Cancer Science and Oncology

Vienna, Austria
February 25-26, 2021

20th Global Summit on Breast Cancer

Amsterdam, Netherlands
April 05-06, 2021

2 nd Global Summit on Oncology and Hematology

Berlin, Germany
April 28-29, 2021

11th World Congress on Breast Cancer

Barcelona, Spain
May 17-18, 2021

8th World Congress on Epigenetics and Chromosome

Zurich, Switzerland
May 17-18, 2021

11th World Congress on Breast Cancer & Therapies

Prague, Czech Republic
June 23-24, 2021

41st Euro Congress on Cancer Science & Therapy

Barcelona, Spain
July 12-13, 2021

World Congress on Women Oncology & Care

Melbourne, Australia
July 12-13, 2021

Global Immuno-Oncology & Biomarkers Summit

Melbourne, Australia
July 29-30, 2021

5th Global Summit on Cancer and Oncology Research

Vienna, Austria
August 13-14, 2021

2nd World Cancer, Oncology and Therapeutics Congress

Munich, Germany
September 20-21, 2021

42nd Annual Summit on Oncology and Cancer

Singapore, Singapore

Cancer Epidemiology, screening, Diagnosis & Prognosis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in